Kye Young Lee
Konkuk University · 207 works · 8,687 citations · h-index 33
Top works
- Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
- Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
- Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
- Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activation
- Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
- PG490 (Triptolide) Cooperates with Tumor Necrosis Factor-α to Induce Apoptosis in Tumor Cells
- Thoracic Manifestation of Churg-Strauss Syndrome
- Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk
- Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
- Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
- Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer
- FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma
- LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) versus gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFR M+) advanced adenocarcinoma of the lung.
- Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions
- Acute respiratory distress syndrome associated with scrub typhus: diffuse alveolar damage without pulmonary vasculitis
- Loss of STAT1 expression confers resistance to IFN‐γ‐induced apoptosis in ME180 cells
- Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non–small-cell Lung Cancer
- IFNα sensitizes ME‐180 human cervical cancer cells to TNFα‐induced apoptosis by inhibiting cytoprotective NF‐κB activation
- Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma
- The Korean guideline for lung cancer screening